Sanofi S.A.. (1/2/17). "Press Release: Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017". Paris & Ingelheim. |
2017-01-02 |
Sanofi S.A.. (1/2/17). "Press Release: Sanofi Pasteur and MSD End Joint Vaccines Business in Europe". Paris. |
2017-01-02 |
MorphoSys AG. (1/3/17). "Press Release: MorphoSys to Present at Upcoming Investor Conferences". Planegg. |
2017-01-03 |
SGS S.A.. (1/3/17). "Press Release: SGS Acquires Laboratoire LCA, Morocco". |
2017-01-03 |
Juno Therapeutics, Inc.. (1/3/17). "Press Release: Juno Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference". Seattle, WA. |
2017-01-03 |
Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of CMO InVivo Biotech to Expand Molecular Biology, Microbiology and Pathology Consumables and Assay Business". Berlin. |
2017-01-04 |
Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of SCiLS GmbH to Advance MALDI Imaging Software Solutions for Life Science, Pharma and Pathology Research Applications". Bremen. |
2017-01-04 |
AiCuris Anti-infective Cures GmbH. (1/4/17). "Press Release: AiCuris Initiates Clinical Development of AIC499, a Novel Resistance-Breaking Antibiotic against a Broad Range of MDR Gram-Negative Bacteria". Wuppertal. |
2017-01-04 |
Affimed N.V.. (1/4/17). "Press Release: Affimed and MD Anderson Announce Clinical Immuno-Oncology Development Collaboration". Heidelberg & Houston, TX. |
2017-01-04 |
Noxxon Pharma N.V.. (1/4/17). "Press Release: Noxxon Pharma Licenses and Assigns Preclinical Spiegelmer Programs to Aptarion. Noxxon Continues Transition to Clinical Oncology Company". Berlin. |
2017-01-04 |
Merck KGaA. (1/4/17). "Press Release: Merck Acquires BioControl to Strengthen Position in Food Safety Testing". Darmstadt. |
2017-01-04 |
Innate Pharma S.A.. (1/4/17). "Press Release: Upcoming Investor Conferences". Marseille. |
2017-01-04 |
Rubius Therapeutics, Inc.. (1/4/17). "Press Release: Rubius Therapeutics Announces Appointment of Top Leadership. Company Taps Industry Leaders Epstein and Straight Nissen to Advance Potential Life Saving Technology Platform". Cambridge, MA. |
2017-01-04 |
InflaRx GmbH. (1/4/17). "Press Release: InflaRx Initiates Exploratory Phase II Trial with IFX-1, a First-in-class Anti-complement C5a Antibody, in Patients with Hidradenitis Suppurativa". Jena. |
2017-01-04 |
Novimmune S.A.. (1/4/17). "Press Release: Novimmune Grants Tiziana an Exclusive License to NI-1201, an anti-IL-6R Monoclonal Antibody for the Treatment of Autoimmune and Inflammatory Diseases". Geneva. |
2017-01-04 |
Xigen S.A.. (1/5/17). "Press Release: Xigen’s Brimapitide, an Innovative JNK Inhibitor, Delivers Positive Phase II Results in Inflammatory Eye Disease". Geneva. |
2017-01-05 |
Valneva S.E.. (1/5/17). "Press Release: Valneva Announces a New Research License Agreement with MSD Animal Health for the Development of Vaccines in the EB66 Cell Line". Lyon. |
2017-01-05 |
HepaRegenix GmbH. (1/5/17). "Press Release: HepaRegenix GmbH Raises EUR9 million in a Series A Financing to Develop Kinase Inhibitors for the Treatment of Acute and Chronic Liver Diseases". Tübingen. |
2017-01-05 |
Phenex Pharmaceuticals AG. (1/5/17). "Press Release: Phenex Receives 100 M USD Milestone Payment from Gilead". Ludwigshafen. |
2017-01-05 |
IDT Biologika GmbH. (1/5/17). "Press Release: IDT Biologika Acquires Ridgeway Biologicals Ltd". Dessau & Compton. |
2017-01-05 |
MorphoSys AG. (1/5/17). "Press Release: Dr. Malte Peters to Become New Chief Development Officer of MorphoSys AG". Planegg. |
2017-01-05 |
Pieris Pharmaceuticals, Inc.. (1/5/17). "Press Release: Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance". Boston, MA & Suresnes. |
2017-01-05 |
Tecan Group Ltd.. (1/5/17). "Press Release: Tecan to Present at J.P. Morgan Healthcare Conference". Männedorf. |
2017-01-05 |
Kite Pharma, Inc.. (1/5/17). "Press Release: Kite Pharma Enhances Commercial Expertise with the Appointment of Ian T. Clark to Its Board of Directors". Santa Monica, CA. |
2017-01-05 |
Bicycle Therapeutics Ltd.. (1/5/17). "Press Release: Bicycle Therapeutics Appoints Nicholas Keen, Ph.D., as Chief Scientific Officer". Cambridge, MA & Cambridge. |
2017-01-05 |
Noxxon Pharma N.V.. (1/6/17). "Press Release: Half-yearly Report on the Liquidity Contract with Invest Securities". Berlin. |
2017-01-06 |
Silence Therapeutics plc. (6/1/17). "Press Release: Hiring of Chief Operating Officer". |
2017-01-06 |
Anokion S.A.. (1/8/17). "Press Release: Anokion Announces Exclusive Strategic Collaboration with Celgene to Develop Novel Tolerance-inducing Therapeutics for Autoimmune Diseases". Lausanne & Cambridge, MA. |
2017-01-08 |
Immunic AG. (1/9/17). "Press Release: Immunic Strengthens Management Team and Supervisory Board". Planegg-Martinsried. |
2017-01-09 |
Eternygen GmbH. (1/9/17). "Press Release: Eternygen GmbH Closes € 8.0 (US$ 8.3) Million Series A Financing led by Epidarex Capital". Berlin. |
2017-01-09 |
Merck KGaA. (1/9/17). "Press Release: Merck and MD Anderson Cancer Center Enter Three-Year Strategic Collaboration". Darmstadt. |
2017-01-09 |
Evotec AG. (1/9/17). "Press Release: Evotec and Eternygen to Develop Novel Metabolic Disease Therapy". Hamburg. |
2017-01-09 |
Qiagen N.V.. (1/9/17). "Press Release: Qiagen Enhances Bioinformatics Portfolio with Acquisition of OmicSoft". Hilden & Germantown, MD. |
2017-01-09 |
Roche. (1/9/17). "Press Release: FDA Grants Roche’s Cancer Immunotherapy Tecentriq (atezolizumab) Priority Review in Additional Type of Advanced Bladder cancer". Basel. |
2017-01-09 |
Silence Therapeutics plc. (1/9/17). "Press Release: Acquisition of Minority Stake in Arrowhead Pharmaceuticals". London. |
2017-01-09 |
Immatics Biotechnologies GmbH. (1/9/17). "Press Release: Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies". Thousand Oaks, CA & Tübingen. |
2017-01-09 |
McDermott Will & Emery. (1/9/17). "Press Release: McDermott Will & Emery Advised Servier in Its Strategic Immuno-oncology Co-development Alliance with Pieris Pharmaceuticals". Paris. |
2017-01-09 |
Merck KGaA. (1/10/17). "Press Release: Merck Expands End-to-End Biodevelopment Centers in North America, China and Europe". Darmstadt. |
2017-01-10 |
Genedata AG. (1/10/17). "Press Release: Genedata Partners with Crescendo Biologics on Next-generation Immuno-Oncology and ADC Programs". Basel. |
2017-01-10 |
Tecan Group Ltd.. (1/10/17). "Press Release: Tecan Appoints Klaus Lun Head of the Life Sciences Business Division". Männedorf. |
2017-01-10 |
Indivumed GmbH. (1/10/17). "Press Release: Indivumed Joins Blood Profiling Atlas in Cancer (Blood PAC)". Hamburg. |
2017-01-10 |
Mologen AG. (1/10/17). "Press Release: Grant to Collaboration Partner for Combination Study in HIV with Lead Product Lefitolimod. Gilead Sciences, Inc. Grant for Aarhus University Hospital". Berlin. |
2017-01-10 |
CureVac AG. (1/11/17). "Press Release: CureVac Provides Clinical Update at 35th Annual J.P. Morgan Healthcare Conference". San Francisco, CA & Tübingen. |
2017-01-11 |
Affimed N.V.. (1/11/17). "Press Release: Affimed Provides Update on NK-Cell Immuno-Oncology Platform". Heidelberg. |
2017-01-11 |
MorphoSys AG. (1/12/17). "Press Release: MorphoSys Partner to Start Phase 2 Trial with Bimagrumab in Obese Patients with Type 2 Diabetes". Planegg. |
2017-01-12 |
Luxendo GmbH. (1/12/17). "Press Release: Luxendo Announces Series A Extension Bringing Total Capital Raised to €8 Million". Heidelberg. |
2017-01-12 |
Evotec AG. (1/12/17). "Press Release: Haplogen’s Novel Antiviral Target Partnered with Evotec Published in »Nature«". Vienna, Amsterdam & Hamburg. |
2017-01-12 |
Merck KGaA. (1/12/17). "Press Release: Merck and Palantir Launch New Healthcare Acceleration Partnership". Palo Alto, CA & Darmstadt. |
2017-01-12 |
Dentons. (1/13/17). "Press Release: Dentons Represents Bayer – Further Sentences in the World's Largest Trial against Drug Counterfeiters". Frankfurt a. M. & Potsdam. |
2017-01-13 |
Eppendorf AG. (1/13/17). "Press Release: William Linton Is New Member of the Supervisory Board". Hamburg. |
2017-01-13 |
ObsEva S.A.. (1/13/17). "Press Release: ObsEva Announces Completion of Phase 1 First-in-Women Study of OBE022 for the Treatment of Preterm Labor". Geneva. |
2017-01-13 |
Silence Therapeutics plc. (1/13/17). "Press Release: Minority Stake in Arrowhead Pharmaceuticals". London. |
2017-01-13 |
Evotec AG. (1/17/17). "Press Release: Evotec and MaRS Innovation Establish Strategic Partnership to Launch Fibrocor Therapeutics". Toronto, ON & Hamburg. |
2017-01-17 |
ObsEva S.A.. (1/17/17). "Press Release: ObsEva Expands Leadership Team and Board of Directors with Industry Veterans". Geneva. |
2017-01-17 |
Protagen AG. (1/17/17). "Press Release: The German National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG Investigate Responsiveness to Checkpoint Inhibitors in Melanoma". |
2017-01-17 |
Indivumed GmbH. (1/17/17). "Press Release: Northwell Health Partners with Indivumed to Create a Cancer Research Biobank". Hamburg. |
2017-01-17 |
Mologen AG. (1/17/17). "Press Release: Convertible Bond Worth €4.99 Million Successfully Placed [Not for United States, Australia, Canada or Japan, et al.]". Berlin. |
2017-01-17 |
InfectoGnostics Forschungscampus Jena e. V.. (1/17/17). "Press Release: MicrobeDx Europe Founded in Jena". |
2017-01-17 |
SGS S.A.. (1/18/17). "Press Release: SGS Opens New Consumer Products Testing Lab in Hai Phong, Vietnam". |
2017-01-18 |
Merck KGaA. (1/18/17). "Press Release: Merck Launches First Commercial Screening Service to Predict Multiple Sources of DNA Damage". Darmstadt. |
2017-01-18 |
Qiagen N.V.. (1/18/17). "Press Release: Qiagen Announces Details for Completion of approximately $250 Million Synthetic Share Repurchase". Venlo. |
2017-01-18 |
Gyros Protein Technologies AB. (1/19/17). "Press Release: Gyros Protein Technologies Appoints Gerrit van den Dool to Board of Directors". Uppsala. |
2017-01-19 |
Evotec AG. (1/19/17). "Press Release: Evotec Enters into an Integrated Drug Discovery Collaboration with Asahi Kasei Pharma (Japan)". Hamburg. |
2017-01-19 |
Genedata AG. (1/19/17). "Press Release: Genedata Launches Data Science Services for Precision Medicine". Basel. |
2017-01-19 |
Affimed N.V.. (1/19/17). "Press Release: Affimed Announces Proposed Public Offering of Common Stock". Heidelberg. |
2017-01-19 |
Elementar UK Ltd.. (1/19/17). "Press Release: Isoprime Ltd Is Changing to Elementar UK". |
2017-01-19 |
Qiagen N.V.. (1/19/17). "Press Release: Qiagen Announces Intention to Adjust the Conversion Ratio under Its 0.375% Senior Unsecured Convertible Notes due 2019 and Its 0.875% Senior Unsecured Convertible Notes due 2021". Venlo. |
2017-01-19 |
AMSilk GmbH. (1/20/17). "Press Release: An Innovative High-performance Material – Biofibers Made from Green Lacewing Silk". |
2017-01-20 |
Affimed N.V.. (1/20/17). "Press Release: Affimed Announces Pricing of Public Offering of Common Stock". Heidelberg. |
2017-01-20 |
CureVac AG. (1/20/17). "Press Release: CureVac’s CEO, Ingmar Hoerr, Appointed by European Commission to High Level Group". Tübingen. |
2017-01-20 |
Merck KGaA. (1/20/17). "Press Release: Merck and Genea Open Centre of Excellence for Fertility [This press release is not intended for U.S. based media]". Darmstadt. |
2017-01-20 |
Merck KGaA. (1/23/17). "Press Release: Merck Announces Research Collaboration with Domain Therapeutics in Immuno-Oncology [Not intended for UK- or US-based media]". Darmstadt. |
2017-01-23 |
Merck KGaA. (1/23/17). "Press Release: Merck Announces Emerging Biotech Grant Program Winners". Darmstadt. |
2017-01-23 |
Enamine Ltd.. (1/23/17). "Press Release: Enamine Expands Collaboration with Europe’s Largest Biopharmaceutical Company". Kiev. |
2017-01-23 |
Roche. (1/23/17). "Press Release: Roche Enters a New Era in Haematology Testing, with the Launch of the New cobas m 511 Analyser". Basel. |
2017-01-23 |
Actelion Ltd.. (1/23/17). "Press Release: Actelion Announces Results of the MAESTRO Study with Macitentan in Patients with Pulmonary Arterial Hypertension Due to Eisenmenger Syndrome". Allschwil. |
2017-01-23 |
Domain Therapeutics S.A.. (1/23/17). "Press Release: Domain Therapeutics and Merck Enter into a License and Collaboration Agreement for Development of Adenosine Receptor Antagonists in Immuno-oncology". Strasbourg. |
2017-01-23 |
DNA Script. (1/23/17). "Press Release: DNA Script Adds Dr. Heiner Dreismann, Former CEO of Roche Molecular Diagnostics, to Board of Directors". Paris. |
2017-01-23 |
SGS S.A.. (1/23/17). "Press Release: SGS 2016 Full Year Results". |
2017-01-23 |
Mologen AG. (1/23/17). "Press Release: Combination Data of TLR9 Agonist Lefitolimod with Checkpoint Inhibitors in Preclinical Tumor Models". |
2017-01-23 |
Bruker Corporation. (1/24/17). "Press Release: Bruker Announces Unique and Comprehensive Workflows for Biopharmaceutical Characterization, Automated by Biopharma Compass 2.0". Washington. |
2017-01-24 |
ObsEva S.A.. (1/25/17). "Press Release: ObsEva SA Announces Pricing of Initial Public Offering". Geneva. |
2017-01-25 |
Wilex AG. (1/25/17). "Press Release: Subsidiary Heidelberg Pharma Exercises Option on BCMA Antibodies of the Max Delbrück Center and Signs License Agreement". Munich. |
2017-01-25 |
Kuros Biosciences AG. (1/25/17). "Press Release: Kuros Closes Acquisition of Xpand Creating a Leading Commercial-stage Orthobiologics Company". |
2017-01-25 |
Affimed N.V.. (1/25/17). "Press Release: Affimed Announces Closing of Public Offering of Common Stock". Heidelberg. |
2017-01-25 |
Qiagen N.V.. (1/26/17). "Press Release: Qiagen’s QuantiFERON-TB Test Wins Tender for Testing of Republic of Korea Armed Forces Recruits". Hilden & Seoul. |
2017-01-26 |
Actelion Ltd.. (1/26/17). "Press Release: Johnson & Johnson to Acquire Actelion for $30 Billion with Spin-out of New R&D Company". New Brunswick, NJ & Allschwil. |
2017-01-26 |
c-LEcta GmbH. (1/26/17). "Press Release: c-LEcta Starts Marketing & Distribution of Denarase". |
2017-01-26 |
Cellestia Biotech AG. (1/26/17). "Press Release: Cellestia Biotech Raises CHF 8 Million Seed Financing from Private Investors and PPF Group to Advance Its Lead Anti-cancer Compound CB-103 to Clinical Development Stage". Basel. |
2017-01-26 |
Caelus Health. (1/26/17). "Press Release: Caelus Health Announces First Closing of a Series A Financing Round to Advance Microbiota-based Therapeutics for Cardio-metabolic Disorders". Amsterdam. |
2017-01-26 |
ViroVet N.V.. (1/27/17). "Press Release: Dr George Gunn, Former CEO of Novartis Animal Health, Appointed as Chairman at ViroVet". Leuven. |
2017-01-27 |
Varex Imaging Corporation. (1/30/17). "Press Release: Varex Imaging Completes Separation from Varian Medical Systems, Lists on the Nasdaq Stock Market". Salt Lake City, UT. |
2017-01-30 |
Evotec AG. (1/30/17). "Press Release: Evotec to Attend Three Upcoming Investor Conferences". Hamburg. |
2017-01-30 |
Qiagen N.V.. (1/30/17). "Press Release: Qiagen Hereditary and Rare Disease Solution Chosen by Genomics England". Hilden & London. |
2017-01-30 |
Technische Universität München. (1/30/17). "Press Release: ProteomeTools – Synthetic Peptides and Spectra for Proteomics.
Milestone for the Analysis of Human Proteomes". |
2017-01-30 |
Sartorius AG. (1/30/17). "Press Release: Sartorius Stedim Biotech – 2016 Targets Fully Achieved; Strong Outlook for 2017". |
2017-01-30 |
Sartorius AG. (1/30/17). "Press Release: Sartorius Grows by Double Digits in Sales Revenue and Earnings in 2016 – Positive Outlook for 2017". Göttingen. |
2017-01-30 |
SGS S.A.. (1/30/17). "Press Release: SGS Issues CHF 375 Million Benchmark Bond [Not for any jurisdiction where unlawful and not for United States]". |
2017-01-30 |
Sonic Healthcare Ltd.. (1/30/17). "Press Release: Acquisition of Medical Laboratory Bremen. Completion of Staber Laboratory Group and GLP Systems Acquisitions". |
2017-01-30 |
Xeltis AG. (1/31/17). "Press Release: FDA Gives Xeltis Go Ahead to Begin Trials in the USA". |
2017-01-31 |